288 related articles for article (PubMed ID: 26057453)
1. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.
Matsushita R; Seki N; Chiyomaru T; Inoguchi S; Ishihara T; Goto Y; Nishikawa R; Mataki H; Tatarano S; Itesako T; Nakagawa M; Enokida H
Br J Cancer; 2015 Jul; 113(2):282-9. PubMed ID: 26057453
[TBL] [Abstract][Full Text] [Related]
2. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
[TBL] [Abstract][Full Text] [Related]
4. Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.
Miyamoto K; Seki N; Matsushita R; Yonemori M; Yoshino H; Nakagawa M; Enokida H
Br J Cancer; 2016 Jul; 115(3):354-63. PubMed ID: 27310702
[TBL] [Abstract][Full Text] [Related]
5. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
6. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
[TBL] [Abstract][Full Text] [Related]
8. Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer.
Liu J; Gu Z; Tang Y; Hao J; Zhang C; Yang X
Cell Cycle; 2018; 17(3):309-318. PubMed ID: 29228869
[TBL] [Abstract][Full Text] [Related]
9. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
Yamasaki T; Yoshino H; Enokida H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Fuse M; Seki N; Nakagawa M
Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464
[TBL] [Abstract][Full Text] [Related]
11. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
13. MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
Yang X; Wang P
Pathol Res Pract; 2019 Nov; 215(11):152598. PubMed ID: 31562019
[TBL] [Abstract][Full Text] [Related]
14. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2.
Liang Y; Zhang D; Li L; Xin T; Zhao Y; Ma R; Du J
Stem Cell Res Ther; 2020 Feb; 11(1):87. PubMed ID: 32102682
[TBL] [Abstract][Full Text] [Related]
16. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
[TBL] [Abstract][Full Text] [Related]
17. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel microRNA targets based on microRNA signatures in bladder cancer.
Ichimi T; Enokida H; Okuno Y; Kunimoto R; Chiyomaru T; Kawamoto K; Kawahara K; Toki K; Kawakami K; Nishiyama K; Tsujimoto G; Nakagawa M; Seki N
Int J Cancer; 2009 Jul; 125(2):345-52. PubMed ID: 19378336
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
